Anticoagulation in elderly patients with atrial fibrillation from the guidelines to the daily medical practice;Terapêutica anti trombótica no idoso com fibrilhação auricular das guidelines à prática clínica

Acta Medica Portuguesa

Volumn 24, Issue SUPPL.2, 2011, Pages 293-300

  Jorge, Elisabete ^a   Pereira, Filipa Seabra ^a   Baptista, Rui ^a   Monteiro, Pedro ^a   Santos, Lèlita ^a   Fonseca, Isabel ^a   Providência, Luís A ^a   Saldanha, M Helena ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Antithrombotic therapy; Atrial fibrillation; Elderly patients; Guidelines; Oral anticoagulation; Risk stratification

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; ELDERLY CARE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MENTAL DISEASE; MORBIDITY; MORTALITY; NEOPLASM; NEUROLOGIC DISEASE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84863444890     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. FUSTER V, RYDÉN LE, CANNOM DS et al: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation. 2007; 7;116-138.
2. SAVELIEVA I, CAMM J: Update on atrial fibrillation:part I. Clin Cardiol. 2008; 31:55-62.
3. FREESTONE B, LIP GYH: Epidemiology and costs of cardiac arrhytmias. In: Lip GYH, Godtfredsen J, eds. Cardiac arrhytmias: a clinical approach. Mosby Edinburg, Scotland, 2003:3-24.
4. THRALL G, LANE D, CARROLL D, LIP GY: Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006; 119:.e1-e19.
5. Kalral, Lip GY: Antithrombotic treatment in atrial fibrillation. Guideline group for the NICE clinical guideline for the management of Atrial Fibrillation; Heart 2007 Jan; 93 (1):39-44.
6. LIP GY, BOSS CJ: Antithrombotic treatment in atrial fibrillation. Heart 2006; 92:39-44.
7. MARINI C, de Santis F, SACCO S, RUSSO T, OLOVIERE L, TOTARO R, CAROLEI AL: Contribution of atrial fibrillation to incidence and outcome of ischaemic stroke: results from a population based study. Stroke 2005; 36:1115-1119.
8. LIP GY, EDWARDS SJ: Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta- analysis. Thomb Res 2006; 118:321-333
9. HART RG, PEARCE LA, AGUILAR MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non valvular atrial fibrilltion. Ann Intern Med 2007; 146:857-867.
10. MANT J, HOBBS FDR, FLETCHER K, ROALFE A, FITZMAURICE D, LIP GY, MURRAY E; BAFTA investigators. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
11. CONNOLLY S, POGUE J, HART R et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006; 10:367-1903
12. NIEUWLAAT R, CAPUCCI A, LIP GY et al: Antithrombotic treatment in real-life atrial fibrillation patients: a report from the EuroHeart Survey on atrial fibrillation. Eur Heart J 2006; 27:3018-3026.
13. DEIDRE A, LIP GY: Barriers to anticoagulation in patients with atrial fibrillation. Stroke 2008; 39:7-9.
14. LIP GY, TSE HF.: Management of atrial fibrillation. Lancet 2007; 370:604-618.
15. GAGE BF, YAN Y, MILLIGAN P et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006; 151,3: 713.
16. HART RG: Atrial Fibrillation and stroke prevention. N Engl J Med 2003; 349:1015-1016.
17. ZEHNDER BS, SCHAER BA, JEKER U, CRON TA, OSSWALD S. Atrial fibrillation: estimated increased rate of stroke due to lacking adherence to guidelines. Swiss Med Wkly 2006; 136:757-760
18. MCBRIDE D, BRUGGENJURGEN B, ROLL S, WILLICH SN. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thrombolysis 2007; 24:65-72.
19. EZEKOWITZ MD, FALK RH. The Increasing Need of Anticoagulant Theraphy to Prevent Stroke in Patients with Atrial Fibrillation. Mayo Clin Proc 2004; 79: 904-013.
20. CONNOLLY SJ, EZEKOWITZ S, YUSUF S et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 17; 361 (12): 1139-1151